Cancer Drugs Fund: approved drugs culled
The NHS England has come under criticism after creating a universal list of oncology medicines that has removed a number of medicines and licences available under the Cancer Drugs Fund.
Read MoreThe NHS England has come under criticism after creating a universal list of oncology medicines that has removed a number of medicines and licences available under the Cancer Drugs Fund.
Read MoreA record haul of ten pharma companies have been found guilty of breaching the ABPI Code at a urology meeting in Ireland last year.
Read MoreCancer charities in are warning the UK Government not to leave patients in the lurch by abruptly pulling the Cancer Drugs Fund next year.
Read MoreAfter a battle lasting more than three years, Roche has finally given in to a campaign from the BMJ and the Cochrane Collaboration to hand over its Tamiflu data.
Read MoreBowel cancer rates among men have risen by nearly 30% in the last 35 years, while women have seen an increase of only 6%, according to a new report from Cancer Research UK.
Read More




PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
